The Evil Diaries: Beximco Pharma, William Hill & Pantheon

Dame Lowell Goddard‘s resignation is in a sense mildly comic. The first two birds, Butler-Sloss and Woolf, were compelled to leave since the leaders of the allegedly abused insisted B-S and W were not impartial since they had had past associations of a very limited nature with those who could potentially be accused or interviewed were they alive – which of course they are not.

Anyway, leaving aside the expense of these changes, one is bound to wonder whether this £100m enquiry can ever get anywhere. It looks to be merely a holding job orchestrated by the Home Office which knows perfectly well that the enquiry is a fool’s errand.

*****

Beximco Pharma (BXP) announces that it is now into the US market for the first time. This is the first time that a manufactured generic pharmaceutical from Bangladesh has been so accepted. Of course, this must mean that many other products follow. The shares are up a bit this morning at 33p but are surely confirmed as a buy under, say, 40p.

*****

William Hill (WMH) announces ordinary results this morning. But this merely means that another bidder will step up to the plate. Now 310p.

*****

Finally, Pantheon (PANR) may offer an encouraging RNS next week: 200p+?